While you clearly set out to test nirsevimab in a population who would not usually be treated with palivizumab as a clinician I would have found it very helpful to know how this treatment compares to an existing treatment (particularly since the main barrier to using palivizumab in this group is not doubts about efficacy but rather about cost effectiveness). Thanks!
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.